���ѵ���

NYU Langone study finds mother-to-child hepatitis B transmission rates reduced with tenofovir.

The study looks at the effect modern practices during a baby’s first year have on long-term health.

Study opens door to future biologic therapies.

A new technique identifies the relationship between fatty acids and breast cancer.

NYU Langone study quantifies nutritional quality of food and drinks endorsed by music celebrities.

Atezolizumab is the first therapy to be approved in more three decades for advanced bladder cancer.

A pattern of “gene dysregulation” causes immune T cells to be less effective against melanoma.

Mice running on cage “exercise” wheels helps explain how exercise benefits a mammal’s brain.

NYU Langone researchers part of team seeking to build a synthetic human genome in a living cell.

A newfound mechanism has implications for immune responses and vaccine design.